137 related articles for article (PubMed ID: 32941279)
1. MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer.
Lord AC; D'Souza N; Shaw A; Rokan Z; Moran B; Abulafi M; Rasheed S; Chandramohan A; Corr A; Chau I; Brown G
Ann Surg; 2022 Aug; 276(2):334-344. PubMed ID: 32941279
[TBL] [Abstract][Full Text] [Related]
2. MRI-predicted extramural vascular invasion and tumour deposit are main predictors of disease-free survival in patients undergoing surgical resection for rectal cancer.
Di Fabio F; Allievi N; Lord A; Bhagwanani A; Venkatasubramaniam A; Arnold S; Moran B
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38170894
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.
Siddiqui MRS; Simillis C; Hunter C; Chand M; Bhoday J; Garant A; Vuong T; Artho G; Rasheed S; Tekkis P; Abulafi AM; Brown G
Br J Cancer; 2017 Jun; 116(12):1513-1519. PubMed ID: 28449006
[TBL] [Abstract][Full Text] [Related]
4. MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy.
Que YT; Chen Y; Yang XY; Ma YR; Liu YY; Wen ZQ; Lu BL; Wu XH; Zhang ZW; Wu YZ; Yu SP; Yuan JP
Eur Radiol; 2023 Oct; ():. PubMed ID: 37840101
[TBL] [Abstract][Full Text] [Related]
5. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer.
Matsunaka T; Goi T; Kurebayashi H; Morikawa M; Okazawa H; Tsujikawa T
Oncology; 2024; 102(2):99-106. PubMed ID: 37562361
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of extramural venous invasion detected by contrast-enhanced CT colonography in colon cancer.
Kato T; Tsukamoto S; Miyake M; Kudose Y; Takamizawa Y; Moritani K; Daiko H; Kanemitsu Y
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38242576
[TBL] [Abstract][Full Text] [Related]
7. Extranodal Extension at Pretreatment MRI and the Prognostic Value for Patients with Rectal Cancer.
Li QY; Yang D; Guan Z; Yan XY; Li XT; Sun RJ; Lu QY; Zhang XY; Sun YS
Radiology; 2024 Mar; 310(3):e232605. PubMed ID: 38530176
[TBL] [Abstract][Full Text] [Related]
8. Adverse impact of tumor deposits in lymph node negative rectal cancer - a national cohort study.
Lundström S; Agger E; Lydrup ML; Jörgren F; Buchwald P
Int J Colorectal Dis; 2023 Mar; 38(1):66. PubMed ID: 36897408
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment.
Geffen EGMV; Nederend J; Sluckin TC; Hazen SJA; Horsthuis K; Beets-Tan RGH; Marijnen CAM; Tanis PJ; Kusters M;
Eur J Surg Oncol; 2024 Mar; 50(6):108307. PubMed ID: 38581757
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of lesion morphology in rectal cancer based on MRI before surgery.
Lv B; Cheng X; Xie Y; Cheng Y; Yang Z; Wang Z; Jin E
BMC Gastroenterol; 2023 Sep; 23(1):318. PubMed ID: 37726671
[TBL] [Abstract][Full Text] [Related]
11. Survey of rectal cancer MRI technique and reporting tumour descriptors in the UK: a multi-centre British Society of Gastrointestinal and Abdominal Radiology (BSGAR) audit.
Robinson E; Balasubramaniam R; Hameed M; Clarke C; Taylor SA; Tolan D; Foley KG
Clin Radiol; 2024 Feb; 79(2):117-123. PubMed ID: 37989667
[TBL] [Abstract][Full Text] [Related]
12. Impact of mesorectal extranodal tumor deposits in magnetic resonance imaging on outcome of rectal cancer patients.
Marjasuo ST; Lehtimäki TE; Koskenvuo LE; Lepistö AH
Eur J Surg Oncol; 2024 Apr; 50(6):108337. PubMed ID: 38657373
[TBL] [Abstract][Full Text] [Related]
13. Prognostic effect of categorized tumor deposits in gastric cancer: A single-center retrospective study.
Hayashi M; Abe M; Fujita T; Matsushita H
Surgery; 2024 Feb; 175(2):373-379. PubMed ID: 37940432
[TBL] [Abstract][Full Text] [Related]
14. Detection of Extranodal Extension at Pretreatment Rectal Cancer MRI: Promising for Staging and Prognosis.
Eberhardt SC
Radiology; 2024 Mar; 310(3):e240582. PubMed ID: 38530177
[No Abstract] [Full Text] [Related]
15. Prediction Model Combining Clinical and MR Data for Diagnosis of Lymph Node Metastasis in Patients With Rectal Cancer.
Xu H; Zhao W; Guo W; Cao S; Gao C; Song T; Yang L; Liu Y; Han Y; Zhang L; Wang K
J Magn Reson Imaging; 2021 Mar; 53(3):874-883. PubMed ID: 32978993
[TBL] [Abstract][Full Text] [Related]
16. Can extranodal tumour deposits be diagnosed on MRI? Protocol for a multicentre clinical trial (the COMET trial).
Lord AC; Moran B; Abulafi M; Rasheed S; Nagtegaal ID; Terlizzo M; Brown G
BMJ Open; 2020 Oct; 10(10):e033395. PubMed ID: 33033006
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Outcomes Associated With MRI-detected Extramural Venous Invasion (mrEMVI) in Rectal Cancer: A Systematic Review and Meta-analysis.
Rouleau Fournier F; Motamedi MAK; Brown CJ; Phang T; Raval MJ; Hague CJ; Karimuddin AA
Ann Surg; 2022 Feb; 275(2):303-314. PubMed ID: 33491979
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI-based radiomics signature for preoperative estimation of tumor-stroma ratio in rectal cancer.
Cai C; Hu T; Gong J; Huang D; Liu F; Fu C; Tong T
Eur Radiol; 2021 May; 31(5):3326-3335. PubMed ID: 33180166
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Importance of MRI-Detected Extramural Venous Invasion in Rectal Cancer: A Literature Review and Systematic Meta-Analysis.
Tan JJ; Carten RV; Babiker A; Abulafi M; Lord AC; Brown G
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):385-394. PubMed ID: 34119593
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Conroy T; Bosset JF; Etienne PL; Rio E; François É; Mesgouez-Nebout N; Vendrely V; Artignan X; Bouché O; Gargot D; Boige V; Bonichon-Lamichhane N; Louvet C; Morand C; de la Fouchardière C; Lamfichekh N; Juzyna B; Jouffroy-Zeller C; Rullier E; Marchal F; Gourgou S; Castan F; Borg C;
Lancet Oncol; 2021 May; 22(5):702-715. PubMed ID: 33862000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
